CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,757,000 | +567.3% | 111,124 | +361.4% | 0.00% | – |
| Q1 2021 | $563,000 | -64.4% | 24,082 | -56.1% | 0.00% | -100.0% |
| Q4 2020 | $1,581,000 | -6.9% | 54,864 | -34.6% | 0.00% | 0.0% |
| Q3 2020 | $1,699,000 | -1.9% | 83,889 | +45.5% | 0.00% | 0.0% |
| Q2 2020 | $1,732,000 | +158.9% | 57,660 | +306.2% | 0.00% | – |
| Q4 2019 | $669,000 | – | 14,194 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 1,401,422 | $42,113,000 | 92.36% |
| VR Adviser, LLC | 4,016,873 | $120,707,000 | 28.90% |
| Svennilson Peter | 6,051,376 | $181,844,000 | 15.21% |
| GREAT POINT PARTNERS LLC | 3,480,000 | $104,574,000 | 8.36% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,237,406 | $37,184,000 | 5.22% |
| Ghost Tree Capital, LLC | 650,000 | $19,533,000 | 5.15% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $42,070,000 | 4.41% |
| Venrock Management V, LLC | 1,557,276 | $46,796,000 | 3.94% |
| Venrock Partners Management V, LLC | 132,026 | $3,967,000 | 3.94% |
| Avoro Capital Advisors LLC | 4,000,000 | $120,200,000 | 2.38% |